Matthew R Dunworth

6PUBLICATIONS
45CO-AUTHORS
Innate immunityEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 19, 2026
Malignant Ascites Harbors Immune Niche with IL-10 Enriched Effector Dysfunction and Persistent Cancer-Binding IgG.

|Aug 25, 2022
A reciprocal translocation involving Aspergillus nidulans snxAHrb1/Gbp2 and gyfA uncovers a new regulator of the G2-M transition and reveals a role in transcriptional repression for the setBSet2 histone H3-lysine-36 methyltransferase.

Steven W James, Jonathan Palmer, Nancy P Keller

|Aug 03, 2022
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin.

Eloïse M Grasset, Matthew Dunworth, Gaurav Sharma

|Feb 09, 2022
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.

Hetakshi Kurani, Seyedeh Fatemeh Razavipour, Kuzhuvelil B Harikumar

|May 16, 2019
DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer.

Meghan Travers, Stephen M Brown, Matthew Dunworth

|Dec 15, 2018
Polyamine Homeostasis in Snyder-Robinson Syndrome.

Tracy Murray-Stewart, Matthew Dunworth, Jackson R Foley

Pageof 1

Frequent Collaborators

3 joint publications

Andrew J Ewald

1 joint publications

Tracy Murray-Stewart

1 joint publications

Kurtis E Bachman

1 joint publications

Seyedeh Fatemeh Razavipour